| Dr Joe J White Jr, MD | |
|
401 Division St Ste 205, South Charleston, WV 25309-1455 | |
| (304) 342-0821 | |
| (304) 345-6679 |
| Full Name | Dr Joe J White Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 401 Division St Ste 205, South Charleston, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013925957 | NPI | - | NPPES |
| 0088033000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 13614 (West Virginia) | Primary |
| Entity Name | Charleston Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124248752 PECOS PAC ID: 3375441637 Enrollment ID: O20031223000426 |
News Archive
People taking prescription opioids to treat moderate to severe pain may be able to breathe a little easier, literally.
Leading research at Newcastle University has been used to shape how dentistry can be carried out safely during the Covid-19 pandemic by mitigating the risks of dental aerosols.
Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).
Janssen Research & Development, LLC announced today that the U.S. Food and Drug Administration has granted Priority Review for the New Drug Application (NDA) for YONDELIS (trabectedin) to treat patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
› Verified 6 days ago
| Entity Name | Charleston Gastroenterology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952483802 PECOS PAC ID: 6709922966 Enrollment ID: O20091002000000 |
News Archive
People taking prescription opioids to treat moderate to severe pain may be able to breathe a little easier, literally.
Leading research at Newcastle University has been used to shape how dentistry can be carried out safely during the Covid-19 pandemic by mitigating the risks of dental aerosols.
Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).
Janssen Research & Development, LLC announced today that the U.S. Food and Drug Administration has granted Priority Review for the New Drug Application (NDA) for YONDELIS (trabectedin) to treat patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joe J White Jr, MD 401 Division St Ste 205, South Charleston, WV 25309-1455 Ph: (304) 342-0821 | Dr Joe J White Jr, MD 401 Division St Ste 205, South Charleston, WV 25309-1455 Ph: (304) 342-0821 |
News Archive
People taking prescription opioids to treat moderate to severe pain may be able to breathe a little easier, literally.
Leading research at Newcastle University has been used to shape how dentistry can be carried out safely during the Covid-19 pandemic by mitigating the risks of dental aerosols.
Tuberculosis is the leading infectious killer in the world, far above AIDS. It kills about 1.6 million of the 10 million it affects every year. About 30,000 patients worldwide now have XDR tuberculosis (that fails to respond to any of the four antibiotic categories in use at present).
Janssen Research & Development, LLC announced today that the U.S. Food and Drug Administration has granted Priority Review for the New Drug Application (NDA) for YONDELIS (trabectedin) to treat patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
› Verified 6 days ago
Dr. William Alexander Wade, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4619 Kanawha Ave., Sw, South Charleston, WV 25309 Phone: 304-400-4545 Fax: 304-400-4546 | |
Dr. Franklin Scott Moore, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4501 Maccorkle Ave Sw, Suite 301, South Charleston, WV 25309 Phone: 304-768-0700 Fax: 304-768-9790 | |
Mohamad Riad Sankari, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 401 Division St Ste 205, South Charleston, WV 25309 Phone: 304-342-0821 Fax: 304-345-6679 | |
Dr. Dina Marie Criniti, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 707 Chestnut St, South Charleston, WV 25309 Phone: 304-768-8500 Fax: 304-768-8530 | |
Emily H Battle, M. D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4607 Maccorkle Ave Sw Ste 406, South Charleston, WV 25309 Phone: 304-766-4342 Fax: 304-766-3541 | |
John Ponugupati, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 401 Division St, Suite 100, South Charleston, WV 25309 Phone: 304-766-4350 Fax: 304-766-4355 |